There are thousands of apps for sleep, stress and mental health. Some offer meditation or journalling; others help with relaxation or mood tracking. They may be useful, but they are not necessarily treatment. An app does not become a treatment simply because it concerns mental health.
Digital Therapeutics—often abbreviated DTx—are developed with a specific therapeutic purpose. A programme may, for example, digitise elements of cognitive behavioural therapy and guide a person through a structured course of education, exercises and homework. A programme for insomnia may work week by week on sleep habits and behaviour; a programme for anxiety may combine psychoeducation with gradual exposure and symptom recording. Some programmes are used independently, while others form part of treatment with a therapist or doctor.
The interesting point is that treatment can continue between consultations. If you see your clinician every second or third week, the rest of life takes place outside the consulting room. A well-designed digital programme can help you practise new strategies in everyday life, record progress and stick to a treatment plan. This may be especially valuable where waiting times are long or access to therapy is limited.
But it is important to distinguish evidence-based treatment from marketing. Many apps look professional and have high user ratings without having been studied as treatments. The greater a digital tool’s clinical significance, the greater the demands should be for evidence, safety, data protection and clear information about who the programme is suitable for. Motivation and digital experience also matter; some people manage a self-directed programme well, while others need support along the way.
The right question is therefore not whether treatment can come from a phone. These are the same questions we should ask of any treatment: Does it work? For whom? Is it safe? What do we do if it does not work? And when is human contact necessary? Software can be part of treatment—but only when it creates genuine clinical value.